Leerink Partnrs Has Weak Estimate for CVS Health Q4 Earnings

CVS Health Co. (NYSE:CVS) – Equities research analysts at Leerink Partnrs reduced their Q4 2024 earnings per share estimates for shares of CVS Health in a report issued on Wednesday, December 18th. Leerink Partnrs analyst M. Cherny now expects that the pharmacy operator will earn $0.98 per share for the quarter, down from their previous estimate of $1.24. The consensus estimate for CVS Health’s current full-year earnings is $5.32 per share. Leerink Partnrs also issued estimates for CVS Health’s Q2 2025 earnings at $1.66 EPS.

CVS Health (NYSE:CVS) last posted its quarterly earnings results on Wednesday, November 6th. The pharmacy operator reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.08 by $0.01. CVS Health had a net margin of 1.36% and a return on equity of 10.72%. The company had revenue of $95.43 billion for the quarter, compared to analyst estimates of $92.72 billion. During the same quarter in the previous year, the firm posted $2.21 earnings per share. The company’s quarterly revenue was up 6.3% compared to the same quarter last year.

Several other brokerages also recently commented on CVS. Truist Financial restated a “buy” rating and issued a $67.00 target price (down previously from $76.00) on shares of CVS Health in a research note on Wednesday, November 20th. StockNews.com downgraded shares of CVS Health from a “hold” rating to a “sell” rating in a report on Thursday, November 14th. TD Cowen boosted their price objective on CVS Health from $73.00 to $80.00 and gave the stock a “buy” rating in a report on Monday, November 25th. UBS Group raised their target price on shares of CVS Health from $60.00 to $62.00 and gave the company a “neutral” rating in a research note on Thursday, November 7th. Finally, Evercore ISI boosted their price target on shares of CVS Health from $62.00 to $75.00 and gave the stock an “outperform” rating in a research note on Tuesday, October 8th. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and thirteen have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $69.12.

CVS Health Price Performance

CVS Health stock opened at $44.25 on Monday. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.80 and a quick ratio of 0.59. CVS Health has a one year low of $43.56 and a one year high of $83.25. The firm has a market capitalization of $55.68 billion, a P/E ratio of 11.23, a PEG ratio of 0.85 and a beta of 0.54. The business has a fifty day moving average price of $55.80 and a 200-day moving average price of $58.10.

Hedge Funds Weigh In On CVS Health

Several hedge funds have recently made changes to their positions in the business. Garland Capital Management Inc. boosted its position in CVS Health by 0.3% during the 2nd quarter. Garland Capital Management Inc. now owns 60,810 shares of the pharmacy operator’s stock valued at $3,591,000 after acquiring an additional 160 shares in the last quarter. Sound Income Strategies LLC increased its holdings in shares of CVS Health by 7.2% during the third quarter. Sound Income Strategies LLC now owns 2,397 shares of the pharmacy operator’s stock valued at $151,000 after acquiring an additional 162 shares in the last quarter. Hexagon Capital Partners LLC boosted its stake in CVS Health by 3.5% in the 3rd quarter. Hexagon Capital Partners LLC now owns 5,268 shares of the pharmacy operator’s stock worth $331,000 after purchasing an additional 178 shares in the last quarter. Bruce G. Allen Investments LLC grew its position in CVS Health by 13.1% during the 3rd quarter. Bruce G. Allen Investments LLC now owns 1,681 shares of the pharmacy operator’s stock valued at $106,000 after purchasing an additional 195 shares during the last quarter. Finally, HHM Wealth Advisors LLC raised its holdings in CVS Health by 11.9% in the second quarter. HHM Wealth Advisors LLC now owns 1,886 shares of the pharmacy operator’s stock worth $111,000 after buying an additional 200 shares during the last quarter. 80.66% of the stock is owned by hedge funds and other institutional investors.

CVS Health Company Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.